In prostate cancer cells, EpCAM has tumor initiation potential and is involved in proliferation, invasion, metastasis and chemo/radiosensitivity via the activation of PI3K/Akt/mTOR signaling pathway (Ni et al., 2013). Here, EPCAM is linked to neoplasm.